Bibliographie (2530)
Systematic review: Telerehabilitation for chronic respiratory disease
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiTelerehabilitation for chronic respiratory disease – Cochrane Library Summary: How does using technology to deliver pulmonary rehabilitation (PR) compare to centre-based PR, or no PR in people with chronic lung disease? – Cochrane Library
The post Systematic review: Telerehabilitation for chronic respiratory disease appeared first on Links Medicus.
Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiAsthma in Adult Patients with COVID-19: Prevalence and Risk of Severe Disease – American Journal of Respiratory and Critical Care Medicine Commentary: Asthma Patients Get Reassurance on COVID-19 — Research review finds no firm evidence of increased risk for severe illness, death – MedPage Today
The post Systematic review: No evidence that patients with asthma are at increased risk of COVID-19 diagnosis, hospitalization or death appeared first on Links Medicus.
UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiUK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus – Biobank Commentary: Covid: Antibodies last at least six months in most – BBC
The post UK Biobank study shows that COVID-19 antibodies remain for at least 6 months post-infection for the vast majority of people who have had the virus appeared first on Links Medicus.
![[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19](/media/k2/items/cache/d18d1528ee4c2188221135de26d79754_M.jpg)
[Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiMore than 50 Long-term effects of COVID-19: a systematic review and meta-analysis – medRxiv Commentary: 80% of COVID-19 Patients May Have Lingering Symptoms, Signs — More than 50 effects persisted after acute infection, meta-analysis shows – MedPage Today (free registration required)
The post [Preprint] Meta-analysis: More than 50 Long-term effects of COVID-19 appeared first on Links Medicus.
Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiTransmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study – The Lancet Infectious Diseases Commentary: Understanding the drivers of transmission of SARS-CoV-2 – The Lancet Infectious Diseases
The post Study shows the viral load of index cases is a leading driver of SARS-CoV-2 transmission appeared first on Links Medicus.
RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19
jeudi, 04 février 2021 04:12 Écrit par Zouhair SouissiAzithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial – The Lancet Invited Commentary: Azithromycin, RECOVERY, and the power of large, simple trials – The Lancet
The post RECOVERY trial: Azithromycin not beneficial for patients admitted to hospital with COVID-19 appeared first on Links Medicus.
Russia’s Sputnik V COVID-19 vaccine candidate appears safe and is 91.6% effective
mercredi, 03 février 2021 06:41 Écrit par Zouhair SouissiSafety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia – The Lancet Commentaries: Sputnik V COVID-19 vaccine candidate appears safe and effective – The Lancet AND Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed […]
The post Russia’s Sputnik V COVID-19 vaccine candidate appears safe and is 91.6% effective appeared first on Links Medicus.
Covid-19: People who have had infection might only need one dose of mRNA vaccine
mercredi, 03 février 2021 06:41 Écrit par Zouhair SouissiCovid-19: People who have had infection might only need one dose of mRNA vaccine – The BMJ Original preprint studies: Robust spike antibody responses and increased reactogenicity in seropositive individuals after a single dose of SARS-CoV-2 mRNA vaccine – medRxiv AND Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2 – medRxiv
The post Covid-19: People who have had infection might only need one dose of mRNA vaccine appeared first on Links Medicus.
Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma
mardi, 02 février 2021 08:29 Écrit par Zouhair SouissiSafety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials – The Lancet Respiratory Medicine (link to abstract – $ for full-text)
The post Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma appeared first on Links Medicus.
Ambulatory management of pulmonary embolism: A comparison of two risk-stratification scores
mardi, 02 février 2021 08:29 Écrit par Zouhair SouissiAmbulatory Management of PE: A Comparison of Two Risk-Stratification Scores – American College of Cardiology
The post Ambulatory management of pulmonary embolism: A comparison of two risk-stratification scores appeared first on Links Medicus.
![[Press release – not published yet] Single-shot Janssen COVID-19 vaccine candidate met primary endpoints in interim analysis of its phase 3 trial](/media/k2/items/cache/51b8ab8a165aa1fb5a57daf7b2513248_XS.jpg)
![[Not published yet] Full-dose Heparin best for moderate COVID-19 regardless of D-dimer — Data released from ACTIV-4a, ATTACC, and REMAP-CAP trials](/media/k2/items/cache/f964ddc910acbc5c426350c1b152e08d_XS.jpg)